Xias Bio
PrivateLast Round
Seed
Sep 4, 2024
Total Funding Raised
$5.1M
Company Overview
Xias Bio operates in Healthcare & Life Sciences and is based in Paisley. Its latest recorded funding round was a Seed round in September 2024.
Xias Bio is a biotechnology company that develops sustainable, animal-free protein alternatives using its proprietary LiteProtein™ engineering platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Fashion & Beauty, Clean Manufacturing
Business Model
B2B
Customer Profile
Data as a Service, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xias Bio Comparables
Compare Xias Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cambrium | 88% | |
| Jellatech | 85% | |
| Geltor | 84% |
For institutional investors. Book with your work email.
Xias Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xias Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Good Startup | Seed |
| Happiness Capital | Seed |
| CPT Capital | Seed |
| IndieBio | Accelerator |
| BoxOne Ventures | Seed |
| SOSV | Accelerator, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 7, 2025
Monthly visitors grew 2240% MoM, reaching 1.1K.
- Dec 13, 2024
Grew 50% QoQ, from 6 to 9 employees.
For institutional investors. Book with your work email.
Xias Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xias Bio's valuation, stock price, and market status.
Is Xias Bio a public or private company?
Xias Bio is a private company.
What is the current stock price of Xias Bio?
Xias Bio is a private company, so its shares have no public market price. Caplight tracks Xias Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xias Bio worth (valuation)?
Valuation information for Xias Bio is not publicly available.
Can I buy Xias Bio stock?
Xias Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xias Bio's last funding round?
Xias Bio's most recent funding round was Seed on September 4, 2024.
Who are the main investors in Xias Bio?
Key investors in Xias Bio include Happiness Capital.
Will Xias Bio IPO soon?
No public IPO plans have been announced for Xias Bio.
How can I track Xias Bio secondary market activity?
Caplight tracks bids, offers, and trades in Xias Bio's shares on secondary markets.